Electro-Optical Sciences Announces Positive Top-Line Results From Landmark MelaFind(R) Pivotal Trial IRVINGTON, NY--(Marketwire - February 13, 2009) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA) today announced positive top-line results of its pivotal trial of MelaFind, a non-invasive,...

Electro-Optical Sciences Announces Participation at the 11th Annual Needham Growth Stock Conference IRVINGTON, NY--(Marketwire - December 31, 2008) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA), a medical device company focused on the design and development of MelaFind®, a...

Electro-Optical Sciences Provides MelaFind(R) Development Update IRVINGTON, NY--(Marketwire - December 29, 2008) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA), a medical device company focused on the design and development of MelaFind®, a...

AAD Launches PSA Campaign on Dangers of Indoor Tanning SCHAUMBURG, IL--(Marketwire - May 5, 2008) - In recognition of Melanoma/Skin Cancer Detection and Prevention Month®, the American Academy of Dermatology (Academy) releases a new public service...